Rhumbline Advisers Intercept Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$9.99 - $18.71 $161,887 - $303,195	16,205 Added 44.25%	52,824 $979,000
Q2 2023 Aug 08, 2023	BUY	$9.17 - $19.29 $22,338 - $46,990	2,436 Added 7.13%	36,619 $405,000
Q1 2023 May 11, 2023	BUY	$12.53 - $21.71 $13,645 - $23,642	1,089 Added 3.29%	34,183 $459,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $18,552 - $25,743	1,598 Added 5.07%	33,094 $409,000
Q3 2022 Nov 10, 2022	BUY	$12.21 - $19.7 $25,482 - $41,113	2,087 Added 7.1%	31,496 $439,000
Q2 2022 Aug 11, 2022	BUY	$11.23 - $19.59 $13,588 - $23,703	1,210 Added 4.29%	29,409 $406,000
Q1 2022 May 12, 2022	SELL	$13.37 - $17.79 $51,233 - $68,171	-3,832 Reduced 11.96%	28,199 $459,000
Q4 2021 Feb 10, 2022	SELL	$14.28 - $19.53 $4,612 - $6,308	-323 Reduced 1.0%	32,031 $522,000
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $13,002 - $20,490	1,001 Added 3.19%	32,354 $480,000
Q2 2021 Aug 05, 2021	BUY	$15.46 - $24.5 $7,730 - $12,250	500 Added 1.62%	31,353 $626,000
Q1 2021 May 06, 2021	SELL	$19.33 - $37.75 $24,278 - $47,414	-1,256 Reduced 3.91%	30,853 $712,000
Q4 2020 Feb 10, 2021	BUY	$24.48 - $42.47 $18,335 - $31,810	749 Added 2.39%	32,109 $793,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $378,586 - $517,566	-9,685 Reduced 23.6%	31,360 $1.3 Million
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $214,960 - $423,660	4,603 Added 12.63%	41,045 $1.97 Million
Q1 2020 May 06, 2020	BUY	$48.35 - $118.68 $28,719 - $70,495	594 Added 1.66%	36,442 $2.29 Million
Q4 2019 Feb 05, 2020	BUY	$57.36 - $124.1 $180,053 - $389,549	3,139 Added 9.6%	35,848 $4.44 Million
Q3 2019 Oct 23, 2019	SELL	$58.69 - $80.46 $3,227 - $4,425	-55 Reduced 0.17%	32,709 $2.17 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $299,414 - $464,618	3,850 Added 13.32%	32,764 $2.61 Million
Q1 2019 May 01, 2019	SELL	$91.83 - $120.68 $20,661 - $27,153	-225 Reduced 0.77%	28,914 $3.23 Million
Q4 2018 Jan 31, 2019	BUY	$85.79 - $126.46 $812,431 - $1.2 Million	9,470 Added 48.15%	29,139 $2.94 Million
Q3 2018 Nov 07, 2018	SELL	$88.49 - $127.55 $131,319 - $189,284	-1,484 Reduced 7.02%	19,669 $2.49 Million
Q2 2018 Aug 06, 2018	BUY	$60.0 - $85.67 $130,860 - $186,846	2,181 Added 11.5%	21,153 $1.78 Million
Q1 2018 May 02, 2018	SELL	$52.72 - $67.25 $25,938 - $33,087	-492 Reduced 2.53%	18,972 $1.17 Million
Q4 2017 Feb 09, 2018	SELL	$58.2 - $72.76 $27,645 - $34,561	-475 Reduced 2.38%	19,464 $1.14 Million
Q3 2017 Nov 06, 2017	BUY	$57.01 - $118.75 $1.14 Million - $2.37 Million	19,939	19,939 $1.16 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account